John Mellors
Vorstandsvorsitzender bei Abound Bio, Inc.
Ursprung des Netzwerks ersten Grades von John Mellors
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Abound Bio, Inc.
 Abound Bio, Inc. BiotechnologyHealth Technology Part of Galapagos NV, Abound Bio, Inc. is a biotechnology company based in Pittsburgh, PA. The company's mission is to generate novel antibody-based biological therapeutics to meet unmet medical needs in the fields of cancer and infectious diseases. Abound Bio's industry-leading human antibody libraries offer size, diversity, and developability advantages that incorporate different binder formats into appropriate therapeutic platforms. The company was founded by Dimiter Dimitrov and John Mellors, with John Mellors serving as CEO since incorporation. Abound Bio was acquired by Galapagos NV on June 21, 2022 for $14 million.
2
| Subsidiary | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John Mellors
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|
Statistik
International
Sektoral
Operativ
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Gabriella Merritt | 1 |
| Dimiter Dimitrov | 1 |
- Börse
- Insiders
- John Mellors
- Unternehmensverbindungen
